Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm
- 31 August 2012
- journal article
- research article
- Published by Elsevier BV in British Journal of Anaesthesia
- Vol. 109 (3), 315-329
- https://doi.org/10.1093/bja/aes264
Abstract
Despite improvements in the clinical management of aneurysmal subarachnoid haemorrhage over the last decade, delayed cerebral ischaemia (DCI) remains the single most important cause of morbidity and mortality in those patients who survive the initial bleed. The pathological mechanisms underlying DCI are still unclear and the calcium channel blocker nimodipine remains the only therapeutic intervention proven to improve functional outcomes after SAH. The recent failure of the drug clazosentan to improve functional outcomes despite reducing vasoconstriction has moved the focus of research into DCI away from cerebral artery constriction towards a more multifactorial aetiology. Novel pathological mechanisms have been suggested, including damage to cerebral tissue in the first 72 h after aneurysm rupture ('early brain injury'), cortical spreading depression, and microthrombosis. A greater understanding of the significance of these pathophysiological mechanisms and potential genetic risk factors is required, if new approaches to the prophylaxis, diagnosis, and treatment of DCI are to be developed. Furthermore, objective and reliable biomarkers are needed for the diagnosis of DCI in poor grade SAH patients requiring sedation and to assess the efficacy of new therapeutic interventions. The purpose of this article is to appraise these recent advances in research into DCI, relate them to current clinical practice, and suggest potential novel avenues for future research.Funding Information
- BJA/RCoA
- National Institute of Academic Anaesthesia
- NIHR Oxford Biomedical Research Centre
- Oxford University Clinical Academic Graduate School
- Medical Research Council
This publication has 137 references indexed in Scilit:
- Delayed Cerebral Ischemia and Spreading Depolarization in Absence of Angiographic Vasospasm after Subarachnoid HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2011
- Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhageJournal of Cerebral Blood Flow & Metabolism, 2011
- Metamorphosis of Subarachnoid Hemorrhage Research: from Delayed Vasospasm to Early Brain InjuryMolecular Neurobiology, 2010
- Clinical Relevance of Cortical Spreading Depression in Neurological Disorders: Migraine, Malignant Stroke, Subarachnoid and Intracranial Hemorrhage, and Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2010
- Recurrent spreading depolarizations after subarachnoid hemorrhage decreases oxygen availability in human cerebral cortexAnnals of Neurology, 2010
- Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhageBrain, 2009
- Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhageSurgical Neurology, 2009
- The impact of anesthetics and hyperoxia on cortical spreading depressionExperimental Neurology, 2008
- Endothelial Nitric Oxide Synthase Gene Single-Nucleotide Polymorphism Predicts Cerebral Vasospasm after Aneurysmal Subarachnoid HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2008
- Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular actionActa Neurochirurgica, 1982